drugset / Trial / NCT06151197
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will assess the efficacy, safety, and tolerability of EN3835 compared to placebo in the treatment of PFI (also known as Ledderhose disease).
Timeline
- Start
- 2023-11-28
- Primary completion
- 2026-06-09
- Completion
- 2026-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Collagenase Clostridium Histolyticum | Protein / enzyme biologic | — | Other |